Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 16.64
+0.12 (0.73%)
Aug 21, 2026, 5:31 PM CET
SWX:SANN Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 254 | 168 | 167 | 90 | 75 | 56 | |
Market Cap Growth | 40.21% | 0.69% | 85.24% | 19.92% | 34.92% | 3.51% |
Enterprise Value | 280 | 191 | 177 | 130 | 103 | 91 |
Last Close Price | 16.64 | 12.60 | 13.82 | 9.81 | 13.80 | 13.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 1.65 | - | - |
Forward PE | - | 1.62 | 1.62 | 1.62 | 105.14 | 105.14 |
PS Ratio | 3.29 | 2.18 | 4.28 | 0.87 | 10.08 | -35.00 |
PB Ratio | -21.48 | -14.26 | 6.04 | 1.51 | -1.72 | 42.04 |
P/FCF Ratio | - | - | - | 1.91 | - | - |
P/OCF Ratio | - | - | - | 1.91 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.63 | 2.48 | 4.53 | 1.26 | 13.82 | - |
EV/EBITDA Ratio | - | - | - | 2.42 | - | - |
EV/EBIT Ratio | - | - | - | 2.54 | - | - |
EV/FCF Ratio | - | - | - | 2.76 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -4.14 | -4.14 | 1.47 | 0.36 | -1.02 | 32.36 |
Debt / EBITDA Ratio | - | - | - | 0.40 | - | - |
Debt / FCF Ratio | - | - | - | 0.46 | - | - |
Net Debt / Equity Ratio | -2.24 | -2.24 | -0.01 | -0.15 | -0.99 | 16.39 |
Net Debt / EBITDA Ratio | -0.81 | -0.81 | 0.01 | -0.16 | -1.01 | -0.41 |
Net Debt / FCF Ratio | -0.76 | -0.76 | 0.01 | -0.19 | -1.44 | -0.58 |
Asset Turnover | 0.51 | 0.51 | 0.30 | 1.19 | 0.10 | - |
Inventory Turnover | 2.93 | 2.93 | 1.61 | 3.37 | 13.40 | 8.29 |
Quick Ratio | 0.78 | 0.78 | 1.19 | 0.71 | 0.05 | 0.71 |
Current Ratio | 1.29 | 1.29 | 1.64 | 0.76 | 0.06 | 0.75 |
Return on Equity (ROE) | -620.02% | -620.02% | -95.79% | 673.95% | - | - |
Return on Assets (ROA) | -15.64% | -15.64% | -15.81% | 36.89% | -36.95% | -39.55% |
Return on Invested Capital (ROIC) | -43.78% | -66.39% | -84.45% | 156.27% | -244.69% | -137.55% |
Return on Capital Employed (ROCE) | -43.80% | -43.80% | -31.20% | 80.10% | -319.80% | -97.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 21, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -19.40% | -29.23% | -25.09% | 60.65% | -94.37% | -99.47% |
FCF Yield | -13.72% | -20.67% | -21.32% | 52.24% | -39.69% | -66.92% |
Buyback Yield / Dilution | -14.29% | -14.29% | -4.24% | -79.29% | -78.31% | -156.61% |